Cargando…
WATCHMAN device-related thrombus successfully treated with apixaban: A case report
RATIONALE: Among atrial fibrillation patients with high risk of bleeding, left atrial appendage occlusion has emerged as an alternative to long-term oral anticoagulation therapy for stroke prevention. Device-related thrombus remains a major concern because it may result in recurrent embolic events....
Autores principales: | Wong, Chun-Ka, Chan, Pak-Hei, Lam, Cheung-Chi, Kwok, On-Hing, Lam, Yat-Yin, Siu, Chung-Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708950/ https://www.ncbi.nlm.nih.gov/pubmed/29381951 http://dx.doi.org/10.1097/MD.0000000000008693 |
Ejemplares similares
-
Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis
por: Jaiswal, Vikash, et al.
Publicado: (2023) -
Acute Device-Related Thrombus after Watchman Device Implant
por: Ajmal, Muhammad, et al.
Publicado: (2019) -
Left atrial thrombus after placement of watchman device
por: Isang, Emmanuel, et al.
Publicado: (2022) -
Embolic Cerebrovascular Accident Secondary to Device-Related Thrombus Post WATCHMAN Device Implantation
por: Patel, Palak, et al.
Publicado: (2022) -
Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study
por: Chen, I-Chih, et al.
Publicado: (2021)